Industry 4.0 Technologies for the Manufacturing and Distribution of COVID-19 Vaccines

1. Zimmer, C, Corum, J, Wee, S-L. Coronavirus vaccine tracker. NY Times. 2020. Accessed October 11, 2021. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
Google Scholar2. Barenji, RV, Akdag, Y, Yet, B, Oner, L. Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Int J Pharm. 2019;567:118445. doi:10.1016/j.ijpharm.2019.06.036
Google Scholar | Crossref | Medline3. Geiger, K. Cloud computing in pharmaceutical R&D: business risks and mitigations. Curr Opin Drug Discov Devel. 2010;13:279-285.
Google Scholar | Medline4. Pesqueira, A, Sousa, MJ, Rocha, Á. Big data skills sustainable development in healthcare and pharmaceuticals. J Med Syst. 2020;44:197. doi:10.1007/s10916-020-01665-9
Google Scholar | Crossref | Medline5. World Bank . Identification for Development. https://id4d.worldbank.org/
Google Scholar6. The World Bank . 1.1 Billion ‘Invisible’ people without ID are priority for new high level advisory council on identification for development. World Bank. 2017. Accessed December 23, 2020. https://www.worldbank.org/en/news/press-release/2017/10/12/11-billion-invisible-people-without-id-are-priority-for-new-high-level-advisory-council-on-identification-for-development
Google Scholar7. Pitrelli, MB. Why ‘immunity passports’ won’t be the golden tickets to travel after all. CNBC. 2020. Accessed December 23, 2020. https://www.cnbc.com/2020/06/04/covid-19-update-will-immunity-passports-let-people-travel-again.html
Google Scholar8. Drew, DA, Nguyen, LH, Steves, CJ, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020;368:1362-1367. doi:10.1126/science.abc0473
Google Scholar | Crossref | Medline9. Ferretti, L, Wymant, C, Kendall, M, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020;368(6491):eabb6936. doi:10.1126/science.abb6936
Google Scholar | Crossref | Medline10. Ciabattini, A, Nardini, C, Santoro, F, Garagnani, P, Franceschi, C, Medaglini, D. Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol. 2018;40:83-94. doi:10.1016/j.smim.2018.10.010
Google Scholar | Crossref | Medline11. Wagner, A, Weinberger, B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front Immunol. 2020;11:717. doi:10.3389/fimmu.2020.00717
Google Scholar | Crossref | Medline12. Ibn Sina, AA, Koo, KM, Ahmed, M, Carrascosa, LG, Trau, M. Interfacial biosensing: direct biosensing of biomolecules at the bare metal interface. In: Wandelt, K , ed. Encyclopedia of Interfacial Chemistry: Surface Science and Electrochemistry. Elsevier; 2018: 269-277. doi:10.1016/B978-0-12-409547-2.14188-5
Google Scholar | Crossref13. Liu, X, Jiang, H. Construction and potential applications of biosensors for proteins in clinical laboratory diagnosis. Sensors. 2017;17:2805. doi:10.3390/s17122805
Google Scholar | Crossref14. Choi, JR. Development of point-of-care biosensors for COVID-19. Front Chem. 2020;8:517. doi:10.3389/fchem.2020.00517
Google Scholar | Crossref | Medline15. Revzin, A, Maverakis, E, Chang, HC. Biosensors for immune cell analysis-a perspective. Biomicrofluidics. 2012;6:21301-2130113. doi:10.1063/1.4706845
Google Scholar | Crossref | Medline16. Yong, B, Shen, J, Liu, X, Li, F, Chen, H, Zhou, Q. An intelligent blockchain-based system for safe vaccine supply and supervision. Int J Inf Manage. 2020;52:102024. doi:10.1016/j.ijinfomgt.2019.10.009
Google Scholar | Crossref17. Center for Disease Control and Prevention . Q and A: fraud and abuse related to 2009 H1N1 influenza vaccine. https://www.cdc.gov/h1n1flu/vaccination/h1n1_fraud_abuse.htm
Google Scholar18. Sarfraz, A, Sarfraz, Z, Sarfraz, M. Survival of the wealthiest? Wait in line for COVID-19 vaccination. Postgrad Med J. Published online August 19, 2021. doi:10.1136/postgradmedj-2021-140970
Google Scholar | Crossref19. Sarfraz, Z, Sarfraz, A, Iftikar, HM, Akhund, R. Is COVID-19 pushing us to the Fifth Industrial Revolution (Society 5.0)? Pak J Med Sci. 2021;37(2):591-594. doi:10.12669/pjms.37.2.3387
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif